Orizal Plus (Olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide)

Olmesartan medoxomil, amlodipine, hydrochlorothiazide, the active ingredients in Orizal Plus, is a combination antihypertensive presented as a tablet for oral use. It treats high blood pressure in adults when monotherapy does not provide adequate control.

GNH USA supplies Orizal Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Orizal Plus is a fixed‑dose combination that addresses hypertension through several complementary mechanisms. - Hypertension: helps achieve target blood pressure when single‑agent therapy is insufficient. - Cardiovascular risk reduction: contributes to lowering the risk of stroke and myocardial infarction in patients with elevated blood pressure. - Renal protection: assists in slowing progression of hypertensive nephropathy by providing consistent blood pressure control.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Peripheral edema: swelling of the lower limbs. - Dizziness or light‑headedness, especially after the first doses. - Flushing: transient warmth or redness of the skin. - Fatigue: general feeling of tiredness. - Increased urination: due to the diuretic component.

Serious or Rare Side Effects: - Severe hypotension: markedly low blood pressure requiring medical attention. - Electrolyte imbalance: especially low potassium or sodium levels. - Acute kidney injury: sudden decline in renal function. - Angio‑edema: rapid swelling of face, lips, tongue or throat. - Liver enzyme elevation: abnormal liver function tests. - Blood dyscrasias: rare blood cell abnormalities.

When prescribing Orizal Plus, clinicians should consider several safety aspects. - Renal impairment: adjust monitoring as the diuretic may affect kidney function. - Hepatic disease: use cautiously, as amlodipine metabolism is hepatic. - Electrolyte disturbances: monitor potassium and sodium levels regularly. - Pregnancy: avoid use; teratogenic risk is associated with angiotensin‑II blockade. - Concomitant antihypertensives: risk of additive blood‑pressure lowering effects. - Store at ambient temperature: keep below 25 °C, protect from moisture and light.

Orizal Plus can interact with several drug classes, requiring clinical awareness.

Major Interactions (Avoid): - Aliskiren: combined use with an ARB may increase risk of renal impairment and hyperkalemia. - Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalemia. - Lithium: increased lithium levels and potential toxicity.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive effect and affect renal function. - ACE inhibitors: concurrent use can increase risk of hypotension and renal dysfunction. - CYP3A4 inhibitors (e.g., clarithromycin, itraconazole): may raise amlodipine concentrations. - Antidiabetic agents: blood‑glucose control may be altered, requiring dose adjustment.